Back to KROS

CHARLES SCHWAB INVESTMENT MANAGEMENT INC → KROS

CHARLES SCHWAB INVESTMENT MANAGEMENT INC KROS Position History

Keros Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$1.9M
Q3 2026
Peak value
$3.8M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$3.8M
Q1 2026$2M
Q2 2026$1.7M
Q3 2026$1.9M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$1.9M170.1K——
Q2 2026$1.7M158.7K——
Q1 2026$2M180.0K——
Q4 2025$3.8M186.8K——

Other funds holding KROS

$288.7M
$240.4M
$182.8M
$175.4M
$171.8M
$163.6M
$161.9M
$144.3M

Other CHARLES SCHWAB INVESTMENT MANAGEMENT INC positions

NVDA

NVIDIA CORPORATION

$38.2B
AAPL

APPLE INC

$34.9B
NVDA

NVIDIA CORPORATION

$32.1B
AAPL

APPLE INC

$29.3B
NVDA

NVIDIA CORPORATION

$29.1B
NVDA

NVIDIA CORPORATION

$28B
MSFT

MICROSOFT CORP

$28B
AAPL

APPLE INC

$27.1B
CHARLES SCHWAB INVESTMENT MANAGEMENT INC KROS Holdings: 13F Position History | Track13F